Scholarlink

<p>Patient-reported outcomes are critical to multidisciplinary, patient-centred approaches in diseases requiring lifelong management. Among inborn errors of immunity (IEIs), reports on this subject are typically limited to specific diagnostic subgroups or focus narrowly on the route of immunoglobulin replacement therapy (IgRT), offering a restricted perspective. We aimed to evaluate the health-related quality of life (HRQoL) and IgRT-related treatment satisfaction (TS) of a heterogeneous cohort of IEI patients and identify factors influencing these outcomes to guide improving the health and well-being of IEI patients. We conducted a cross-sectional survey targeting IEI patients on IgRT, assessing TS (TSQM-9) and HRQoL (KINDL/SF-36). Patient/caregiver-reported data were integrated with clinical data to identify outcomes and influencing factors. The survey included 500 IEI patients (356 children, 144 adults) diagnosed 54% Primary Antibody Deficiency (PAD), 36% combined immunodeficiency, 7% immune-dysregulation, and 3% other IEIs. Non-PAD diagnoses, comorbidities, absence of school/work attendance, and IgRT-related systemic adverse reactions negatively impacted HRQoL. Severe infections and related hospitalizations adversely influenced both HRQoL and TS. The subcutaneous route of IgRT, particularly at home, was associated with higher TS due to its convenience and reduced school/work absenteeism. However, the IgRT route did not influence adult HRQoL. Patient-reported well-being and satisfaction in IEIs are multifactorial and cannot be solely attributed to the route of IgRT. Minimizing negative experiences related to the disease or its treatment and, where possible, encouraging patients to maintain school/work attendance or engage in activities that promote societal participation can enhance self-esteem, coping abilities, and overall well-being.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Multidimensional Assessment of Patient-Reported-Outcomes in a Multicenter Cohort of Inborn Errors of Immunity

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月6日

查看全文
  • Melek Yorgun Altunbas,
  • Asena Pinar Sefer,
  • Sevgi Bilgic-Eltan,
  • Cebbar Yildirimcakar,
  • Pelin Ozturk,
  • Ümmügülsüm Dikici,
  • Ece Tüsüz Önata,
  • Özge Atik,
  • Hatice Eke-Gungor,
  • Burcu Kolukisa,
  • Hayrunnisa Bekis Bozkurt,
  • Gaye Kocatepe,
  • Şefika İlknur Kökcü Karadağ,
  • Aysu İlhan Yalaki,
  • Zeycan Canitez Oral,
  • Nagihan Iskender,
  • Tuğba Kıratlı Kıratlı Yolcu,
  • Dilan Şirin,
  • Reyhan Gumusburun,
  • Demet Tekcan,
  • Iknur Kulhas Celik,
  • Salim Can,
  • Razin Amirov,
  • Necmiye Ozturk,
  • Selcen Bozkurt,
  • Burkay Cagan Colak,
  • Ramin Mahmudov,
  • Ezgi Yalcın Gungoren,
  • Esra Karabiber,
  • Hasibe Artac,
  • Omur Ardeniz,
  • Isıl Eser Simsek,
  • Fatih Çelmeli,
  • Tuğba Arikoglu,
  • Deniz Özçeker,
  • Dilara Kocacik Uygun,
  • Aysen Bingol,
  • Fatma Merve Tepetam,
  • Öner Özdemir,
  • Muhlis Cem Ar,
  • Ebru Arik Yilmaz,
  • Ahmet Ozen,
  • Safa Baris,
  • Elif Karakoc-Aydiner

摘要

Patient-reported outcomes are critical to multidisciplinary, patient-centred approaches in diseases requiring lifelong management. Among inborn errors of immunity (IEIs), reports on this subject are typically limited to specific diagnostic subgroups or focus narrowly on the route of immunoglobulin replacement therapy (IgRT), offering a restricted perspective. We aimed to evaluate the health-related quality of life (HRQoL) and IgRT-related treatment satisfaction (TS) of a heterogeneous cohort of IEI patients and identify factors influencing these outcomes to guide improving the health and well-being of IEI patients. We conducted a cross-sectional survey targeting IEI patients on IgRT, assessing TS (TSQM-9) and HRQoL (KINDL/SF-36). Patient/caregiver-reported data were integrated with clinical data to identify outcomes and influencing factors. The survey included 500 IEI patients (356 children, 144 adults) diagnosed 54% Primary Antibody Deficiency (PAD), 36% combined immunodeficiency, 7% immune-dysregulation, and 3% other IEIs. Non-PAD diagnoses, comorbidities, absence of school/work attendance, and IgRT-related systemic adverse reactions negatively impacted HRQoL. Severe infections and related hospitalizations adversely influenced both HRQoL and TS. The subcutaneous route of IgRT, particularly at home, was associated with higher TS due to its convenience and reduced school/work absenteeism. However, the IgRT route did not influence adult HRQoL. Patient-reported well-being and satisfaction in IEIs are multifactorial and cannot be solely attributed to the route of IgRT. Minimizing negative experiences related to the disease or its treatment and, where possible, encouraging patients to maintain school/work attendance or engage in activities that promote societal participation can enhance self-esteem, coping abilities, and overall well-being.